Forus

AI for prior authorizations & medication access support

Forus logo
201-500 employees
  • Healthcare
  • B2C
  • B2B
  • Artificial Intelligence
  • Biotechnology
SoHo, New York, NY

Company mission

To accelerate medicine for the people who need it, prescribe it, and create it.

Our take

Forus, formerly known as Tandem, leverages AI to make accessing medication faster, easier and cheaper for patients. The company handles logistics across doctors, insurers, and pharmacies so that people can get the drugs they need without the normal hassle.

By managing the entire prescription process end-to-end, Forus is eliminating painful administrative work for both patients and doctors. Its streamlined approach means that people can get life-changing therapeutics much quicker and cheaper than through usual processes.

Forus' business model is based on using the network they are building to support life sciences companies in bringing new drugs to market. The data and user connectivity can support pharmaceutical companies with clinical trials, new drug launches, and patient access programs.

Because of this approach, Forus has seen exponential growth, building a large network of users across all 50 states. It's an exciting two-sided model from the company, and one which has seen it raise substantial funding. This supports further expansion across medical specialities.

Kirsty headshot

Kirsty

Company Specialist at Welcome to the Jungle

Benefits

  • Fully covered medical,
vision, and dental insurance
  • Memberships for One Medical,
Talkspace, Teladoc, and Kindbody
  • 401K plan, FSA option,
commuter benefits, and DashPass
  • Unlimited paid time off (PTO)
and 16 weeks of parental leave
  • Lunch at the office every
day and dinner after 7 PM

Funding (2 rounds)

May 2026

$123m

LATE VC

Jan 2024

$30m

SERIES A

Total funding: $153m

This company has top investors

Leadership

Sahir Jaggi

(Founder & CEO)

Spent 6 years at Oscar Health, ultimately as Director of Product Strategy. Prior to this, they were a Venture Partner at Rough Draft Ventures, Product Manager at Blue Apron and Biomedical Researcher at Columbia University.